Hypoglycemia, a dangerous drop in blood glucose levels related to insulin and sulfonylurea (SU) use, has been identified as one of the top three preventable adverse drug events by the U.S. Department of Health and Human Services. Yet the prevalence and high burden of disease in patients with type 2 diabetes (T2D), particularly the elderly, are often underappreciated in clinical settings. Supporting the early identification and management of those at greatest risk is critical.
From bench to bedside and all the stages in between, the Hormone Health Network is committed to supporting patient and public education.
Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.
Read our special collection of journal articles focused on diabetes! These were published in 2018-19, with curation guided by Altmetric Attention Score and Feature Article designation.
